+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Incretin Based Drugs"

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • December 2023
  • 230 Pages
  • Global
From
Incretin-based Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Incretin-based Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Incretin Based Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Incretin Based Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 104 Pages
  • Global
From
Incretin-Based Drugs Market By Drug Class, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Incretin-Based Drugs Market By Drug Class, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • December 2023
  • 250 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Incretin Based Drugs market is a subset of the Endocrine and Metabolic Disorders Drugs market. Incretin Based Drugs are used to treat type 2 diabetes, a chronic condition in which the body does not produce enough insulin or does not use insulin effectively. These drugs work by increasing the amount of insulin released by the pancreas in response to a meal, and by decreasing the amount of glucose produced by the liver. They also help to reduce appetite and slow the absorption of glucose from the intestines. Commonly prescribed Incretin Based Drugs include GLP-1 agonists, DPP-4 inhibitors, and SGLT-2 inhibitors. Notable companies in the Incretin Based Drugs market include Novo Nordisk, Eli Lilly, Merck, AstraZeneca, and Boehringer Ingelheim. Show Less Read more